The Roadmap

Building the operating system for Indian Pharma

We started by giving field forces a system they actually want to use. We built HRMS to end the monthly reconciliation fight. But we are just getting started. Here is a look at what is actively in development and coming next.

Conversational Analytics

Talk to your data in plain English.

Stop asking IT to build new dashboards. Our upcoming AI integration lets you ask complex, multi-layered questions and instantly generates the answers you need to manage your field force.

Expense vs. Reality

"Which MRs have travel claims exceeding GPS distance by >20%?"

Sample ROI Analysis

"Identify territories consuming the most samples but showing lowest sales growth."

Burnout Prediction

"Which top 20% performers are showing early behavioral signs of burnout?"

The intelligent future of field operations

We are moving beyond simple data capture. The next generation of PharmaMonitor actively works for you—finding anomalies, driving growth, and automating compliance.

AI across every module

In development

Over the next six months, AI is being woven into the fabric of every module. Instead of asking managers to review thousands of records, the system will surface the handful of days, claims, and patterns that actually require human attention.

AI Insight: Expense Anomaly

Flagged 2 DCRs where claimed TA distance exceeds GPS plot by >40%.

Growth & Performance

Planned

Tying actual field achievements directly into the annual review process, removing the guesswork and letting hard numbers drive promotions.

Manufacturing Suite

In dev

Batch records, quarantine to QA release, and Schedule M compliant audit trails. Built specifically for Indian facilities.

e-Signatures
Schedule M Audit
QC Release Workflows

Deeper Finance Integration

Planned

Bridging the gap between field expense claims, payroll payouts, and your core accounting software.

Field
ERP

Items marked in development or planned are our direction of travel, not commitments, and may change. Nothing on this page is sold on the strength of something we have not built — if a capability matters to your decision, ask us on the call and we will tell you plainly whether it exists today.